WASHINGTON, D.C. — ACLA President Julie Khani today issued the following statement regarding the current stimulus bill under consideration in the Senate: “ACLA members have ... Read More
WASHINGTON, D.C. — As commercial laboratories rapidly extend considerable resources to meet demand for COVID-19 testing, ACLA President Julie Khani sent a letter to congressional ... Read More
WASHINGTON, D.C. – Following the FDA’s actions announced on March 16, ACLA President Julie Khani released the following statement: “The FDA’s guidance released on Saturday, February 29th cleared ... Read More
Commercial capacity is expected to exceed 20,000 tests per day nationwide by end of next week, 280,000 tests per week by April 1. WASHINGTON, D.C. ... Read More
Last Updated March 2023 Recent Updates Letter (March 21, 2022): COVID Relief Funding Letter Blog (March 1, 2022): An Emerging Crisis of Undiagnosed Diseases and ... Read More
WASHINGTON, D.C. – The FDA’s latest guidance released over the weekend provided an accelerated path for high-complexity laboratories to support additional testing capacity in response to the COVID-19 outbreak. ... Read More
WASHINGTON, D.C. — Following the introduction of the Verifying Accurate Leading-edge IVCT Development Act of 2020, ACLA President Julie Khani issued the following statement: “ACLA and ... Read More
Following ongoing developments related to COVID-19 testing and response, included below is a statement from ACLA President Julie Khani following today’s meeting with the White ... Read More
